Conjugation of a cyclometalated Ir( iii ) complex to human serum albumin for oncosis-mediated photodynamic therapy
Inorganic Chemistry Frontiers · 2025 · 12 (22) · 7068-7082
DOI: 10.1039/d5qi01287b ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry Frontiers, 2025. Verfasst von Antonio Linero-Artiaga und 5 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Aventis Foundation, Paul-Ehrlich-Gesellschaft Stiftung, Federación Española de Enfermedades Raras.
Abstract (Originalsprache)
We report on the first photo-responsive metallodrug–albumin conjugate capable of inducing oncosis in cancer cells.
Förderung
- Aventis Foundation
- Paul-Ehrlich-Gesellschaft Stiftung
- Federación Española de Enfermedades Raras
- Universidad de Murcia
- Fonds der Chemischen Industrie
- Ministerio de Ciencia y Tecnología
Zitieren
APA
Linero-Artiaga, A., Servos, L., Papadopoulos, Z., Rodríguez, V., Ruiz, J., & Karges, J. (2025). Conjugation of a cyclometalated Ir( iii ) complex to human serum albumin for oncosis-mediated photodynamic therapy. Inorganic Chemistry Frontiers, 12(22), 7068-7082. https://doi.org/10.1039/d5qi01287b
Vancouver
Linero-Artiaga A, Servos L, Papadopoulos Z, Rodríguez V, Ruiz J, Karges J. Conjugation of a cyclometalated Ir( iii ) complex to human serum albumin for oncosis-mediated photodynamic therapy. Inorganic Chemistry Frontiers. 2025;12(22):7068-7082. doi:10.1039/d5qi01287b
BibTeX
@article{LineroArtiaga2025,
author = {Linero-Artiaga, Antonio and Servos, Lisa-Marie and Papadopoulos, Zisis and Rodríguez, Venancio and Ruiz, José and Karges, Johannes},
title = {Conjugation of a cyclometalated Ir( iii ) complex to human serum albumin for oncosis-mediated photodynamic therapy},
journal = {Inorganic Chemistry Frontiers},
year = {2025},
volume = {12},
number = {22},
pages = {7068--7082},
doi = {10.1039/d5qi01287b}
}
EUVIMED